Anbio Biotechnology (NNNN) Accounts Payables (2023 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Historic Accounts Payables for Anbio Biotechnology (NNNN) over the last 2 years, with Q4 2024 value amounting to $1.6 million.

• Anbio Biotechnology's Accounts Payables rose 9648.83% to $1.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.6 million, marking a year-over-year increase of 9648.83%. This contributed to the annual value of $1.6 million for FY2024, which is 9648.83% up from last year.
• Anbio Biotechnology's Accounts Payables amounted to $1.6 million in Q4 2024, which was up 9648.83% from $827151.0 recorded in Q4 2023.
• Over the past 5 years, Anbio Biotechnology's Accounts Payables peaked at $1.6 million during Q4 2024, and registered a low of $827151.0 during Q4 2023.

Peer Comparison